MarginsXMarginsX
Home › Markets › Health Care › COGT

Cogent Biosciences Inc. (COGT)

COGT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$27.44
-3.92% on the day
Market cap
$4.8B
Mid cap
Revenue · 2020
$7.9M
-65.0% on 2019
Net income · 2020
-$74.8M
-950.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2020-12-31, https://www.sec.gov/Archives/edgar/data/1622229/000156459022010238/0001564590-22-010238-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2020-12-31.

Profile

FieldValue
TickerCOGT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2018
SEC CIK0001622229
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2020

LineValue
Revenue$7.9M
Net income-$74.8M
Operating income-$82.2M
Net margin-950.4%
Operating margin-1044.3%
Revenue growth-65.0%
Cash$242.2M
Total assets$250.9M
P/E (computed)Net income was not positive
P/S (computed)606.6×

Warning signs

Cash runway
8.1 months
$217.5M cash at September 30, 2026
Share count, 1 year
+22.2%
2025-11-05 to 2026-11-03 · +102.0% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$383.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$217.5M cash; operating cash flow -$81.0M a quarter.Report 2026-09-30
Shares outstanding173,994,452 (2026-11-03); 142,376,529 a year earlier; 86,124,249 three years earlier.Cover page 2026-11-03
Reverse splits, 3 years1; latest on 2024-06-05Source 2024-06-05
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-08-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-02-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $383.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$111.4M-$80.8M$217.5M$223.7MNeeds four quarters10-Q 2026-11-05
Q2 2026
2026-06-30
Not filed-$96.4M-$77.3M$181.2M$223.5MNeeds four quarters10-Q 2026-11-05
Q1 2026
2026-03-31
Not filed-$97.4M-$86.9M$241.2M$223.2MNeeds four quarters10-Q 2026-11-05
Q4 2025
2025-12-31
Not filed-$102.5M-$79.1M$312.0M$222.9MNeeds four quarters10-K 2026-02-17
Q3 2025
2025-09-30
Not filed-$80.9M-$64.3M$125.3M$44.3MNeeds four quarters10-Q 2026-11-05
Q2 2025
2025-06-30
Not filed-$73.5M-$54.5M$127.6M$43.9MNeeds four quarters10-Q 2026-11-05
Q1 2025
2025-03-31
Not filed-$72.0M-$66.5M$126.0MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q4 2024
2024-12-31
Not filed-$67.9M-$60.6M$98.2M$0Needs four quarters10-K 2026-02-17

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-10
Latest annual report10-K2026-02-17
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 616 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-9.7%
1 month+1.7%
3 months-23.5%
Year to date-19.6%
1 year-15.6%
From 52-week high-33.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TVTXTravere Therapeutics Inc.$49.70-1.88%$4.8B
EWTXEdgewise Therapeutics Inc.$43.68-4.90%$4.8B
IONSIonis Pharmaceuticals Inc.$28.01-3.61%$4.7B
DNTHDianthus Therapeutics Inc.$89.55-2.46%$5.0B
LQDALiquidia Corporation$56.37-1.81%$5.1B
PTCTPTC Therapeutics Inc.$60.97-3.97%$5.1B
ERASErasca Inc.$15.11-3.51%$5.3B
MANEVeradermics Incorporated$128.05-1.24%$5.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier